Cardiovascular devices market seen reaching $100.37B by 2030

The Business Research Company says the cardiovascular devices market will rise from $72.22 billion in 2025 to $76.6 billion in 2026, with growth accelerating through 2030. The report points to rising cardiovascular disease, higher healthcare spending and expanding use of AI-enabled diagnostics, minimally invasive devices and remote monitoring.

Why it matters: - Cardiovascular devices are central to diagnosing, monitoring and treating heart disease, which remains a major global health burden. - The market’s projected rise signals more demand for procedures, implants, monitoring tools and newer cardiac technologies. - The report links market growth to rising disease prevalence and broader healthcare investment, both of which can expand access to treatment.

What happened: - The Business Research Company released a cardiovascular devices market report on July 30, 2026. - The report estimates the market will grow from $72.22 billion in 2025 to $76.6 billion in 2026. - The report projects the market will reach $100.37 billion by 2030. - The report says North America was the largest regional market in 2025, followed by Western Europe. - Africa was the smallest regional market in the global study.

The details: - The report forecasts a 6.1% compound annual growth rate in 2026 and a 7.0% CAGR through 2030. - Growth drivers include rising incidence of cardiovascular diseases, more interventional cardiology procedures, advances in surgical methods and wider availability of cardiac care infrastructure. - Greater use of implantable cardiac devices is also supporting expansion. - The report flags structural heart interventions, AI-enabled cardiac diagnostics, outpatient cardiovascular treatments and next-generation cardiovascular technologies as major growth areas. - Innovation in biocompatible and intelligent materials is another expected driver. - Trend lines include minimally invasive cardiovascular devices, transcatheter therapies, imaging-guided interventions, remote cardiac monitoring and device miniaturization. - Cardiovascular devices help maintain heart function and regulate blood flow in patients with heart rhythm disorders or weakened cardiac performance. - The report says increasing cardiovascular disorders are a primary market driver. - The American Heart Association reported in January 2024 that the age-adjusted U.S. cardiovascular death rate reached 233.3 per 100,000 people, up 4.0% from 224.4 a year earlier. - The report says higher healthcare spending also supports device adoption. - The UK Office for National Statistics said total healthcare expenditure rose 5.6% in nominal terms in 2023, a 0.9% increase from 2022. - The report covers Asia-Pacific, South East Asia, Eastern Europe, South America and the Middle East in addition to North America, Western Europe and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - The forecast suggests the market is moving from broad demand tied to disease prevalence toward more specialized growth driven by advanced interventions, diagnostics and remote care. - The emphasis on AI, imaging and minimally invasive tools points to a shift toward devices that reduce procedure burden and support faster decision-making. - Regional leadership by North America likely reflects more established cardiac care infrastructure and faster adoption of advanced devices.

What's next: - The market’s next phase will likely be shaped by adoption of structural heart therapies, outpatient treatment models and connected monitoring. - Continued investment in biocompatible materials and smaller devices could help expand use across more procedures and care settings. - The report’s 2030 forecast suggests steady expansion if cardiovascular disease rates and healthcare spending keep rising. - More information is available on The Business Research Company.